Lirentelimab (Anti-Siglec-8)
Lirentelimab (Anti-Siglec-8) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). It can be used for the research of eosinophilic gastritis and duodenitis. MW :150 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2619 |
| Sku # | A2619-1mg*5 |
| Pricing | 1mg*5, $970.00 |